Human IGFBP6 enzyme-linked immunoassay kit(one step)

CAT: EHY0336 Datasheet
Specification 96 Test
Sensitivity 0.01ng/ml (50 μl);0.06ng/ml (10 μl);
Standard Curve Range 0.14 ~100 ng/ml
Standard Curve Gradient 7 Points/3 Folds
Number of Incubations 1
Detectable sample serum, plasma
Sample Volume 50 μl/10 μl
Type Fully Ready-to-Use
Operation Duration 60min
ng/ml O.D. Average Corrected
0.00 0.0129 0.0134 0.0132
0.14 0.0244 0.0238 0.0241 0.0110
0.41 0.0473 0.0467 0.0470 0.0339
1.23 0.1208 0.1193 0.1201 0.1069
3.70 0.3341 0.3367 0.3354 0.3223
11.11 1.0190 1.0020 1.0105 0.9974
33.33 2.5820 2.5930 2.5875 2.5744
100.00 4.0854 4.1603 4.1229 4.1097

Precision

Intra-assay Precision Inter-assay Precision
Sample Number S1 S2 S3 S1 S2 S3
22 22 22 6 6 6
Average(ng/ml) 1.8 9.1 32.6 3.1 11.9 28.5
Standard Deviation 0.1 0.3 1.1 0.1 0.4 0.5
Coefficient of Variation(%) 3.1 2.9 3.5 3.0 3.5 1.8

Intra-assay Precision (Precision within an assay) Three samples of known concentration were tested twenty-two times on one plate to assess intra-assay precision. Inter-assay Precision (Precision between assays) Three samples of known concentration were tested six times on one plate to assess intra-assay precision.

Spike Recovery

The spike recovery was evaluated by spiking 3 levels of Human IGFBP6 into health human serum sample. The un-spiked serum was used as blank in this experiment.
The recovery ranged from 84% to 119% with an overall mean recovery of 105%.

Sample Values

Sample Matrix Sample Evaluated Range (ng/ml) Detectable (%) Mean of Detectable (ng/ml)
Serum3050.24-536.72100261.23

Serum/Plasma – Thirty samples from apparently healthy volunteers were evaluated for the presence of Human IGFBP6 in this assay. No medical histories were available for the donors. n.d. = non-detectable. Samples measured below the sensitivity are considered to be non-detectable.

Background: IGFBP6

The superfamily of insulin-like growth factor (IGF) binding proteins include the six high-affinity IGF binding proteins (IGFBP) and at least four additional low-affinity binding proteins referred to as IGFBP related proteins (IGFBP-rP). All IGFBP superfamily members are cysteine-rich proteins with conserved cysteine residues, which are clustered in the amino- and carboxy-terminal thirds of the molecule. IGFBPs modulate the biological activities of IGF proteins. Some IGFBPs may also have intrinsic bioactivity that is independent of their ability to bind IGF proteins. Post-transitional modifications of IGFBP, including glycosylation, phosphorylation and proteolysis, have been shown to modify the affinities of the binding proteins to IGF. Human IGFBP-6 cDNA encodes a 240 amino acid (aa) residue precursor protein with a putative 24 aa residue signal peptide that is processed to generate the 216 aa residue mature protein that is O-glycosylated. IGFBP-6 is expressed in ovarian cells, prostatic cells, and fibroblasts. IGFBP-6 is found predominantly in CSF and serum. IGFBP-6 binds preferentially to IGF-II, exhibiting a 2-fold higher affinity for IGF-II than for IGF-I.

Under construction!

Under construction!

Under construction!

Contact Information
Related Products
相关途径
Guarantee